SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-011784
Filing Date
2018-05-08
Accepted
2018-05-08 16:02:35
Documents
9
Period of Report
2018-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20180508.htm 8-K 27101
2 EX-99.1 sndx-ex991_6.htm EX-99.1 159981
3 GRAPHIC g201805081642568892235.jpg GRAPHIC 2883
4 GRAPHIC g201805081642567642232.jpg GRAPHIC 2883
5 GRAPHIC g201805081642562542229.jpg GRAPHIC 2883
6 GRAPHIC g201805081642567692233.jpg GRAPHIC 2883
7 GRAPHIC g201805081642568222234.jpg GRAPHIC 2883
8 GRAPHIC g201805081642567492231.jpg GRAPHIC 2883
9 GRAPHIC g201805081642564932230.jpg GRAPHIC 2883
  Complete submission text file 0001564590-18-011784.txt   217173
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 18814460
SIC: 2834 Pharmaceutical Preparations